Should I buy or sell CONMED stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last twelve months. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNMD shares. View CNMD analyst ratings or view top-rated stocks .

What is CONMED's stock price target for 2024?

7 Wall Street research analysts have issued 1-year price targets for CONMED's shares. Their CNMD share price targets range from $98.00 to $141.00. On average, they predict the company's share price to reach $120.43 in the next twelve months. This suggests a possible upside of 69.8% from the stock's current price. View analysts price targets for CNMD or view top-rated stocks among Wall Street analysts .

How have CNMD shares performed in 2024?

CONMED's stock was trading at $109.51 on January 1st, 2024. Since then, CNMD shares have decreased by 35.2% and is now trading at $70.94. View the best growth stocks for 2024 here .

When is CONMED's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024. View our CNMD earnings forecast .

How can I listen to CONMED's earnings call?

CONMED will be holding an earnings conference call on Wednesday, April 24th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link .

How were CONMED's earnings last quarter?

CONMED Co. (NYSE:CNMD) released its earnings results on Wednesday, January, 31st. The company reported $1.06 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.11 by $0.05. The company had revenue of $327.05 million for the quarter, compared to the consensus estimate of $332.94 million. CONMED had a trailing twelve-month return on equity of 13.69% and a net margin of 5.18%.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED declared a quarterly dividend on Monday, February 26th. Shareholders of record on Friday, March 15th will be given a dividend of $0.20 per share on Friday, April 5th. This represents a $0.80 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend is Thursday, March 14th. Read our dividend analysis for CNMD .

Is CONMED a good dividend stock?

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 1.03%. The dividend payout ratio is 39.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNMD will have a dividend payout ratio of 14.11% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CNMD .

What ETFs hold CONMED's stock?

ETFs with the largest weight of CONMED (NYSE:CNMD) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH) , SPDR S&P Health Care Equipment ETF (XHE) , Mid Cap US Equity Select ETF (RNMC) , SPDR S&P SmallCap 600 ESG ETF (ESIX) and SPDR S&P 600 Small Cap ETF (SLY) . iShares U.S. Medical Devices ETF (IHI) .

What guidance has CONMED issued on next quarter's earnings?

CONMED updated its FY 2024 earnings guidance on Wednesday, January, 31st. The company provided earnings per share (EPS) guidance of 4.300-4.400 for the period, compared to the consensus earnings per share estimate of 4.400. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

Who are CONMED's major shareholders?

CONMED's stock is owned by a number of institutional and retail investors. Top institutional investors include Mountain Pacific Investment Advisers Inc. ID (0.81%), Portman Square Capital LLP (0.00%), Epiq Partners LLC (0.04%), Diversified Trust Co (0.04%) and AdvisorNet Financial Inc (0.01%). Insiders that own company stock include Brian Concannon , Curt R Hartman , Daniel S Jonas , John D Ferrell, Johonna Marie Pelletier, Peter K Shagory , Stanley W Peters III , Todd W Garner and Todd W Garner . View institutional ownership trends .

How do I buy shares of CONMED?

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:CNMD

CONMED (CNMD) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free CNMD Stock Alerts

$71.08

-1.68 (-2.31%)

(As of 04:35 PM ET)

Compare

Today's Range: $70.57
▼
$72.79
50-Day Range: $72.80
▼
$87.76
52-Week Range: $70.57
▼
$138.47

Volume: 620,019 shs
Average Volume: 555,011 shs
Market Capitalization: $2.19 billion

P/E Ratio: 34.84
Dividend Yield: 1.13%
Price Target: $120.43

Get CONMED alerts:

CONMED MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.86 Rating Score
Upside/Downside: 69.8% Upside
$120.43 Price Target
Short Interest: Bearish
13.22% of Shares Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: -0.74
Upright™ Environmental Score
News Sentiment: -0.26
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 30.65%
From $4.34 to $5.67 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.77 out of 5 stars

Medical Sector

41st out of 914 stocks

Electromedical Equipment Industry

1st out of 20 stocks

3.4

Analyst's Opinion

Consensus Rating
CONMED has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 6 buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
CONMED has only been the subject of 4 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
13.22% of the outstanding shares of CONMED have been sold short.
Short Interest Ratio / Days to Cover
CONMED has a short interest ratio ("days to cover") of 7.3.
Change versus previous month
Short interest in CONMED has recently increased by 3.56%, indicating that investor sentiment is decreasing.

2.5

Dividend Strength

Dividend Yield
CONMED pays a meaningful dividend of 1.03%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
CONMED does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of CONMED is 39.22%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, CONMED will have a dividend payout ratio of 14.11% next year. This indicates that CONMED will be able to sustain or increase its dividend.

4.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
CONMED has received a 64.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Surgical instruments", "Medical technology engineering", and "Training for medical professionals" products. See details.
Environmental Sustainability
The Environmental Impact score for CONMED is -0.74.

1.5

News and Social Media Coverage

News Sentiment
CONMED has a news sentiment score of -0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for CONMED this week, compared to 3 articles on an average week.
Search Interest
8 people have searched for CNMD on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
MarketBeat Follows
Only 2 people have added CONMED to their MarketBeat watchlist in the last 30 days. This is a decrease of -71% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CONMED insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 7.60% of the stock of CONMED is held by insiders.

4.4

Earnings and Valuation

Earnings Growth
Earnings for CONMED are expected to grow by 30.65% in the coming year, from $4.34 to $5.67 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of CONMED is 34.77, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 139.35.
Price to Earnings Ratio vs. Sector
The P/E ratio of CONMED is 34.77, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 210.87.
Price to Earnings Growth Ratio
CONMED has a PEG Ratio of 0.70. PEG Ratios below 1 indicate that a company could be undervalued.
Price to Book Value per Share Ratio
CONMED has a P/B Ratio of 2.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About CONMED Stock (NYSE:CNMD)

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CNMD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CNMD Stock News Headlines

April 17, 2024 | americanbankingnews.com

CONMED (CNMD) Scheduled to Post Earnings on Wednesday

April 14, 2024 | americanbankingnews.com

CONMED (NYSE:CNMD) Sets New 1-Year Low at $74.19

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 10, 2024 | finance.yahoo.com

Should You Invest in CONMED (CNMD)?

April 10, 2024 | nasdaq.com

Validea Detailed Fundamental Analysis - CNMD

April 9, 2024 | americanbankingnews.com

Guided Therapeutics (OTCMKTS:GTHP) and CONMED (NYSE:CNMD) Financial Review

April 2, 2024 | finance.yahoo.com

CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024

March 25, 2024 | investorplace.com

3 Retirement Stocks to Buy at a 52-Week Low in March

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 19, 2024 | finance.yahoo.com

Earnings growth of 23% over 3 years hasn't been enough to translate into positive returns for CONMED (NYSE:CNMD) shareholders

March 16, 2024 | finance.yahoo.com

CNMD Apr 2024 120.000 call

March 16, 2024 | finance.yahoo.com

CNMD Apr 2024 90.000 put

February 27, 2024 | msn.com

CONMED Corporation declares $0.20 dividend

February 27, 2024 | businesswire.com

CONMED Corporation Announces Quarterly Cash Dividend

February 21, 2024 | ca.finance.yahoo.com

CNMD Mar 2024 80.000 call

February 17, 2024 | finance.yahoo.com

CNMD Mar 2024 80.000 put

February 17, 2024 | finance.yahoo.com

CNMD Mar 2024 105.000 call

February 17, 2024 | finance.yahoo.com

CNMD Mar 2024 90.000 put

February 3, 2024 | finance.yahoo.com

CONMED Corporation (NYSE:CNMD) Just Reported Earnings, And Analysts Cut Their Target Price

February 2, 2024 | finance.yahoo.com

What Does CONMED Corporation's (NYSE:CNMD) Share Price Indicate?

February 2, 2024 | markets.businessinsider.com

Cracking The Code: Understanding Analyst Reviews For Conmed

February 1, 2024 | marketwatch.com

Conmed Shares Sink 11% After Forecasting Slower FY24 Growth

February 1, 2024 | markets.businessinsider.com

Piper Sandler Reaffirms Their Buy Rating on Conmed (CNMD)

February 1, 2024 | finance.yahoo.com

CONMED Corporation (NYSE:CNMD) Q4 2023 Earnings Call Transcript

February 1, 2024 | finance.yahoo.com

Conmed Corp (CNMD) Reports Record Revenue Growth and Strong Earnings in Q4 and Full-Year 2023

February 1, 2024 | markets.businessinsider.com

These Analysts Revise Their Forecasts On CONMED After Q4 Results

January 31, 2024 | finance.yahoo.com

Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings

See More Headlines

Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 1/31/2024
Ex-Dividend for 4/5 Dividend: 3/14/2024
Dividend Payable: 4/05/2024
Today: 4/18/2024
Next Earnings (Confirmed): 4/24/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: NYSE:CNMD
CUSIP: N/A
CIK: 816956
Web: www.conmed.com
Phone: (727) 392-6464
Fax: 315-797-0321
Employees: 4,000
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $120.43
High Stock Price Target: $141.00
Low Stock Price Target: $98.00
Potential Upside/Downside: +67.2%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.86
Research Coverage: 7 Analysts

Profitability

EPS (Most Recent Fiscal Year): $2.04
Trailing P/E Ratio: 35.31
Forward P/E Ratio: 16.60
P/E Growth: 0.7
Net Income: $64.46 million
Net Margins: 5.18%
Pretax Margin: 6.49%
Return on Equity: 13.69%
Return on Assets: 4.67%

Debt

Debt-to-Equity Ratio: 1.17
Current Ratio: 1.98
Quick Ratio: 0.96

Sales & Book Value

Annual Sales: $1.24 billion
Price / Sales: 1.78
Cash Flow: $5.63 per share
Price / Cash Flow: 12.79
Book Value: $27.13 per share
Price / Book: 2.65

Miscellaneous

Outstanding Shares: 30,790,000
Free Float: 28,451,000
Market Cap: $2.22 billion
Optionable: Optionable
Beta: 1.33

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Curt R. Hartman (Age 60)
Chairman of the Board, CEO & President
Comp: $1.5M
Mr. Todd W. Garner (Age 55)
Executive VP & CFO
Comp: $783.48k
Ms. Heather L. Cohen (Age 51)
Executive VP and Chief Human Resources & Legal Officer
Comp: $561.01k
Mr. Patrick J. Beyer (Age 58)
President of International & Global Orthopedics
Comp: $1.22M
Mr. Stanley W. Peters III (Age 49)
President of Advanced Surgical & Advanced Endoscopic Technologies
Comp: $648.12k
Mr. Peter K. Shagory (Age 55)
Executive Vice President of Strategy & Corporate Development
Ms. Shanna L. Cotti-Osmanski (Age 47)
Executive VP of Information Technology & CIO
Mr. John Ferrell (Age 56)
Executive Vice President of Human Resources
Mr. Daniel S. Jonas Esq. (Age 60)
Special Counsel & Corporate Secretary
Comp: $646.48k
Mr. David R. Murray (Age 76)
President of ConMed Electrosurgery
Comp: $469.17k

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CNMD Stock Analysis - Frequently Asked Questions

Should I buy or sell CONMED stock right now?: 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last twelve months. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNMD shares.
View CNMD analyst ratings or view top-rated stocks.
What is CONMED's stock price target for 2024?: 7 Wall Street research analysts have issued 1-year price targets for CONMED's shares. Their CNMD share price targets range from $98.00 to $141.00. On average, they predict the company's share price to reach $120.43 in the next twelve months. This suggests a possible upside of 69.8% from the stock's current price.
View analysts price targets for CNMD or view top-rated stocks among Wall Street analysts.
How have CNMD shares performed in 2024?: CONMED's stock was trading at $109.51 on January 1st, 2024. Since then, CNMD shares have decreased by 35.2% and is now trading at $70.94.
View the best growth stocks for 2024 here.
When is CONMED's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our CNMD earnings forecast.
How can I listen to CONMED's earnings call?: CONMED will be holding an earnings conference call on Wednesday, April 24th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.
How were CONMED's earnings last quarter?: CONMED Co. (NYSE:CNMD) released its earnings results on Wednesday, January, 31st. The company reported $1.06 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.11 by $0.05. The company had revenue of $327.05 million for the quarter, compared to the consensus estimate of $332.94 million. CONMED had a trailing twelve-month return on equity of 13.69% and a net margin of 5.18%.

How often does CONMED pay dividends? What is the dividend yield for CONMED?: CONMED declared a quarterly dividend on Monday, February 26th. Shareholders of record on Friday, March 15th will be given a dividend of $0.20 per share on Friday, April 5th. This represents a $0.80 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend is Thursday, March 14th.
Read our dividend analysis for CNMD.
Is CONMED a good dividend stock?: CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 1.03%. The dividend payout ratio is 39.22%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CNMD will have a dividend payout ratio of 14.11% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CNMD.
What ETFs hold CONMED's stock?: ETFs with the largest weight of CONMED (NYSE:CNMD) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), Mid Cap US Equity Select ETF (RNMC), SPDR S&P SmallCap 600 ESG ETF (ESIX) and SPDR S&P 600 Small Cap ETF (SLY).iShares U.S. Medical Devices ETF (IHI).
What guidance has CONMED issued on next quarter's earnings?: CONMED updated its FY 2024 earnings guidance on Wednesday, January, 31st. The company provided earnings per share (EPS) guidance of 4.300-4.400 for the period, compared to the consensus earnings per share estimate of 4.400. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.
Who are CONMED's major shareholders?: CONMED's stock is owned by a number of institutional and retail investors. Top institutional investors include Mountain Pacific Investment Advisers Inc. ID (0.81%), Portman Square Capital LLP (0.00%), Epiq Partners LLC (0.04%), Diversified Trust Co (0.04%) and AdvisorNet Financial Inc (0.01%). Insiders that own company stock include Brian Concannon, Curt R Hartman, Daniel S Jonas, John D Ferrell, Johonna Marie Pelletier, Peter K Shagory, Stanley W Peters III, Todd W Garner and Todd W Garner.
View institutional ownership trends.
How do I buy shares of CONMED?: Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CNMD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CONMED (CNMD) Stock Price, News & Analysis

CONMED MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About CONMED Stock (NYSE:CNMD)

CNMD Stock Price History

CNMD Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

CNMD Stock Analysis - Frequently Asked Questions

Overall MarketRank^™